Crohn's disease is an inflammatory disease of the gastrointestinal tract accompanied by occasional intestinal manifestations characterized by transmural inflammation, healing and exacerbations, which can involve more than one part of the gastrointestinal tract.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Crohn's disease is an inflammatory disease of the gastrointestinal tract accompanied by occasional intestinal manifestations characterized by transmural inflammation, healing and exacerbations, which can involve more than one part of the gastrointestinal tract.
📊
Key Findings & Data:Crohn's disease is an inflammatory disease of the gastrointestinal tract accompanied by occasional intestinal manifestations characterized by transmural inflammation, healing and exacerbations, which can involve more than one part of the gastrointestinal tract.
💡
Conclusion & Impact:Crohn's disease is an inflammatory disease of the gastrointestinal tract accompanied by occasional intestinal manifestations characterized by transmural inflammation, healing and exacerbations, which can involve more than one part of the gastrointestinal tract.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Crohn's disease is an inflammatory disease of the gastrointestinal tract accompanied by occasional intestinal manifestations characterized by transmural inflammation, healing and exacerbations, which can involve more than one part of the gastrointestinal tract.
Özet
Crohn hastalığı gastrointestinal sistemin, ağızdan anüse kadar, herhangi bir yerini tutabilen, iyileşme ve alevlenme dönemleri ile seyreden en sık 15-35 yaş ve 55-65 yaşları arasında görülen etyolojisinde genetik faktörlerin, defektif immün regülasyonun, infeksiyon ajanlarının ve sigaranın suçlandığı bağırsağın inflamatuar hastalığıdır. Komplikasyonlarla karşılaşılması durumunda tedavi cerrahidir.
🔖
Cite This Article
BADAK, B., BASPINAR, M., YAŞAR, N. F. (2018). Ischemic Crohn’s Disease; Nonsurgical Remission; Case Report. Causapedia, Cilt: 7 - Sayı: 2, 76–81. https://ajindex.com/articles/144820
McDowell C, Bhimji S S. Bowel, Inflammatory Disease (IBD). StatPearls. Last Update: December 5, 2017. Dietz D, et al. Safety and long-term efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn’s disease. J Am Coll Surg. 2001; 192:330-7.
Devecioğlu S, Savaşan MK, Kaya M. Granülomatöz kolit. 2. baskı. Sayek I, editör. Temel Cerrahi. Ankara:Güneş Kitabevi; 1996;1118-23. Maartense S, et al. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg. 2006;243:143-9.
Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum. 2002;45:771-5. Hazlewood GS, et al. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis. Gastroenterology. 2015;148:344–54. Singh S, et al. Postoperative mortality among patients with inflammatory bowel diseases: a systematic review and meta-analysis of population-based studies. Gastroenterology. 2015;149:928–37.
Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2016;152:313–21.e2. Fichera A, Michelassi F. Surgical treatment of Crohn's disease. J Gastrointest Surg. 2007;11:791–803.